The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ya.A. Sliman

Burdenko Neurosurgical Center;
Moscow Institute of Physics and Technology (National Research University)

N.S. Samoylenkova

Burdenko Neurosurgical Center

O.M. Antipova

Lomonosov Moscow State University

V.A. Brylev

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

D.A. Veryutin

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

K.A. Sapozhnikova

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

A.I. Alekseeva

Avtsyn Research Institute of Human Morphology of federal state budgetary scientific institution «Petrovsky national research centre of surgery»;
Institute of Higher Nervous Activity and Neurophysiology

I.N. Pronin

Burdenko Neurosurgical Center

A.M. Kopylov

Lomonosov Moscow State University

G.V. Pavlova

Burdenko Neurosurgical Center;
Institute of Higher Nervous Activity and Neurophysiology;
Sechenov First Moscow State Medical University

Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells

Authors:

Ya.A. Sliman, N.S. Samoylenkova, O.M. Antipova, V.A. Brylev, D.A. Veryutin, K.A. Sapozhnikova, A.I. Alekseeva, I.N. Pronin, A.M. Kopylov, G.V. Pavlova

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2024;88(1): 48‑55

Views: 697

Downloaded: 26


To cite this article:

Sliman YaA, Samoylenkova NS, Antipova OM, Brylev VA, Veryutin DA, Sapozhnikova KA, Alekseeva AI, Pronin IN, Kopylov AM, Pavlova GV. Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells. Burdenko's Journal of Neurosurgery. 2024;88(1):48‑55. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20248801148

Recommended articles:
Early progression of glioblastoma before radiotherapy. Burdenko's Journal of Neurosurgery. 2023;(3):40-46
Extent of rese­ction in patients with glioblastoma. Burdenko's Journal of Neurosurgery. 2023;(5):63-68
PET/CT with 11C-methionine in asse­ssment of brain glioma meta­bolism. Burdenko's Journal of Neurosurgery. 2024;(1):63-69
Predictors for primary progression in glioblastoma. P.A. Herzen Journal of Onco­logy. 2023;(5):13-19

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.